Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged, disseminated globally and become a leading cause of bacterial infections in both health …
C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020 - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not …
Importance Methicillin-resistantStaphylococcus aureus (MRSA) bacteremia is associated with mortality of more than 20%. Combining standard therapy with a β-lactam antibiotic has …
NM Brown, AL Goodman, C Horner… - JAC-antimicrobial …, 2021 - academic.oup.com
These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007–18) pertaining to …
SYC Tong, J Mora, AC Bowen… - Clinical Infectious …, 2022 - academic.oup.com
Staphylococcus aureus bloodstream (SAB) infection is a common and severe infectious disease, with a 90-day mortality of 15%–30%. Despite this,< 3000 people have been …
HF Chambers, AS Bayer - New England Journal of Medicine, 2020 - Mass Medical Soc
Key Clinical Points Native-Valve Infective Endocarditis The modified Duke criteria, which are based on findings on physical examination, echocardiography, microbiologic studies, and …
K Davar, D Clark, RM Centor… - Open Forum …, 2023 - academic.oup.com
Like all fields of medicine, Infectious Diseases is rife with dogma that underpins much clinical practice. In this study, we discuss 2 specific examples of historical practice that have …
M Pujol, JM Miró, E Shaw, JM Aguado… - Clinical Infectious …, 2021 - academic.oup.com
Background We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus …